Antidote treatment

Active Awarded Last action

Contract number
SPE2DP26F4183
Awardee
Awarding agency
Obligated
$36,470,000

Award facts

Contract value 100% obligated
$36,470,000.00 Current and potential, with all options
Completion date 62% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Available for Competition Only One Source
Pricing
Firm Fixed Price
Place of performance
St. Louis, MO 63146, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award 8512025830 ! Antidote treatment $36,470,000

About this award

The Defense Logistics Agency Medical Supply Chain issued a $36.47 million delivery order to Meridian Medical Technologies, LLC on April 7, 2026, for antidote treatment supplies with an ultimate completion date of February 26, 2027.

Meridian manufactures and supplies autoinjector devices and nerve agent antidote treatments, including DuoDote autoinjectors combining atropine and pralidoxime chloride for chemical and biological defense preparedness and emergency medical response. Place of performance is St. Louis, MO. The order is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract SPE2DP26F4183?

SPE2DP26F4183 was awarded to Meridian Medical Technologies, LLC by Medical Supply Chain (Troop Support) on April 7, 2026.

How much is contract SPE2DP26F4183 worth?

The government has obligated $36,470,000 on SPE2DP26F4183.

Is contract SPE2DP26F4183 an order under another contract?

Yes. SPE2DP26F4183 is a delivery order under SPE2DP26D0001, an indefinite delivery contract.

Was contract SPE2DP26F4183 competed?

The extent of competition for SPE2DP26F4183 was not available for competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award